We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App





Rapid Saliva Tests as Good as PCR Tests for Diagnosing COVID-19 in Early Phase of Infection

By LabMedica International staff writers
Posted on 11 Nov 2021
Print article
Illustration
Illustration

Researchers investigating whether rapid antigen testing can be used on saliva instead of swabbing the nasal cavity have found that saliva can be good enough for diagnosing COVID-19 in the early phase of infection.

The study from Lund University (Lund, Sweden) aimed to find out if rapid COVID-19 tests using saliva could be easier alternatives to the common PCR tests which involve a nose and throat sample taken with a cotton swab - a procedure that is often unpleasant. Quick diagnostic tools are crucial in reducing the spread of COVID-19. Today, there are several different test methods to identify an ongoing infection. The PCR tests used in healthcare and most commercially available antigen tests are usually taken with swabs in the nasal cavity - a method that many find uncomfortable. Antigen tests are used as a complement to PCR testing when increased test capacity or rapid test results are required. However, there are also saliva tests.

In the current study, the researchers compared RT-PCR tests with saliva samples they collected from 44 patients. All 44 participants had confirmed COVID-19, and had to clear their throat before spitting. The results showed that coronavirus can be detected in both saliva and nasal cavity samples, but that the concentrations are slightly lower in saliva. The researchers also examined four different rapid antigen tests available on the market, to see how well they detect the virus in saliva samples. All four antigen tests were found to be relatively sensitive in detecting the virus early in the infection, as the virus concentration is higher at that point. Later in the infection, when the virus concentration is lower, the antigen tests were not sufficiently sensitive. The researchers believe that rapid saliva tests are a good alternative to standard PCR testing, and can also supplement these methods as screening needs increase.

“Although our study isn’t definitive, our results indicate that rapid tests using saliva might be good enough for diagnosing COVID-19 in the early phase of infection”, said Magnus Rasmussen, specialist in infectious disease medicine at Skåne University Hospital and professor at Lund University, who led the study.

“The advantage of a saliva-based rapid test is that you can easily take it at home in peace and quiet. For many, it can make a big difference. If infection occurs in, for example, primary school, the younger unvaccinated students can be screened more quickly with a saliva-based rapid test. For children, it is important that sampling is simple and without discomfort”, added Yang de Marinis, who is the first author of the study.

Related Links:
Lund University 

Gold Supplier
SARS-CoV-2 RT-PCR Assay
Reliance SARS-CoV-2 RT-PCR Assay Kit
New
Silver Supplier
Bacteriuria Test Strips
MAST Bacteruritest Strips
New
Pancreatic Elastase ELISA Kit
Pancreatic Elastase ELISA
New
Semi-Automated Coagulation Analyzer
Thrombo Fast+

Print article

Channels

Hematology

view channel
Image: Atellica Solution (Photo courtesy of Siemens Healthineers)

Siemens Introduces New Intelligent, Integrated IVD Solutions Virtually at EUROMEDLAB 2021

Siemens Healthineers (Erlangen, Germany) introduced new intelligent, integrated IVD solutions virtually at the XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab... Read more

Immunology

view channel
Image: The Luminex 200 Instrument System sets the standard for multiplexing, providing the ability to perform up to 100 different tests in a single reaction volume on a flow cytometry-based platform (Photo courtesy of Luminex Corp)

Inflammatory Cytokines Measured in Infants Born to Preterm Preeclamptic Mothers

Preeclampsia is both a vascular and inflammatory disorder. The pathophysiology of preeclampsia is complex and rooted in the interplay between maternal and placental factors with the key characteristics... Read more

Microbiology

view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more

Pathology

view channel
Image: The Ventana BenchMark Ultra autostainer is for cancer diagnostics with automation and the test menu include IHC, ISH, and FITC tests (Photo courtesy of Ventana Medical System)

Specific Biomarker Investigated for Triple-Negative Breast Cancer Diagnosis

Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression and comprises a heterogeneous... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Lateral Flow Assay Market to Reach Nearly USD 6.5 Billion by 2031 Due to Surge in Demand for Rapid POC Testing

The global lateral flow assay market is projected to grow at a CAGR of around 5% from USD 3.7 billion in 2020 to over USD 6.4 billion by 2031, driven by the growing adoption of home-based lateral flow... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.